Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes

In type 2 diabetes, prolonged dysregulation of signalling and ß-cell metabolic control leads to ß-cell dysfunction, and is increasingly associated with abnormal metabolic states which disrupt normal cellular physiology. Utilization of appropriate ß-cell models enables a systematic approach to unders...

Full description

Bibliographic Details
Main Authors: Rowlands, J., Walz, N., Rowles, J., Keane, Kevin, Carlessi, Rodrigo, Newsholme, P.
Format: Journal Article
Published: Humana Press 2019
Online Access:http://hdl.handle.net/20.500.11937/74054
_version_ 1848763167690194944
author Rowlands, J.
Walz, N.
Rowles, J.
Keane, Kevin
Carlessi, Rodrigo
Newsholme, P.
author_facet Rowlands, J.
Walz, N.
Rowles, J.
Keane, Kevin
Carlessi, Rodrigo
Newsholme, P.
author_sort Rowlands, J.
building Curtin Institutional Repository
collection Online Access
description In type 2 diabetes, prolonged dysregulation of signalling and ß-cell metabolic control leads to ß-cell dysfunction, and is increasingly associated with abnormal metabolic states which disrupt normal cellular physiology. Utilization of appropriate ß-cell models enables a systematic approach to understand the impact of perturbations to the biological system. The BRIN-BD11 ß-cell line is a useful, pre-clinical cell model for ß-cell dysfunction associated with type 2 diabetes, among other metabolic disorders. The present chapter describes detection and analysis of ß-cell dysfunction with respect to changes in bioenergetics and metabolism, generation of intracellular reactive oxygen species, and acute and chronic insulin secretion in the BRIN-BD11 cell line.
first_indexed 2025-11-14T10:59:10Z
format Journal Article
id curtin-20.500.11937-74054
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:59:10Z
publishDate 2019
publisher Humana Press
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-740542019-07-31T05:37:55Z Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes Rowlands, J. Walz, N. Rowles, J. Keane, Kevin Carlessi, Rodrigo Newsholme, P. In type 2 diabetes, prolonged dysregulation of signalling and ß-cell metabolic control leads to ß-cell dysfunction, and is increasingly associated with abnormal metabolic states which disrupt normal cellular physiology. Utilization of appropriate ß-cell models enables a systematic approach to understand the impact of perturbations to the biological system. The BRIN-BD11 ß-cell line is a useful, pre-clinical cell model for ß-cell dysfunction associated with type 2 diabetes, among other metabolic disorders. The present chapter describes detection and analysis of ß-cell dysfunction with respect to changes in bioenergetics and metabolism, generation of intracellular reactive oxygen species, and acute and chronic insulin secretion in the BRIN-BD11 cell line. 2019 Journal Article http://hdl.handle.net/20.500.11937/74054 10.1007/978-1-4939-8994-2_32 Humana Press restricted
spellingShingle Rowlands, J.
Walz, N.
Rowles, J.
Keane, Kevin
Carlessi, Rodrigo
Newsholme, P.
Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title_full Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title_fullStr Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title_full_unstemmed Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title_short Method Protocols for Metabolic and Functional Analysis of the BRIN-BD11 ß-Cell Line: A Preclinical Model for Type 2 Diabetes
title_sort method protocols for metabolic and functional analysis of the brin-bd11 ß-cell line: a preclinical model for type 2 diabetes
url http://hdl.handle.net/20.500.11937/74054